Wang D, Hu B, Hu C, Xiong, Zhao, Li, Wang X, Peng (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 323(11):1061–1069. https://doi.org/10.1001/jama.2020.1585
Article
CAS
PubMed
PubMed Central
Google Scholar
Holshue ML, DeBolt C, Lindquist S, Lindquist S, Lofy KH, Wiesman J, Bruce H, Spitters C, Ericson K, Sara Wilkerson MN, Tural A, Diaz G, Cohn A, Fox LA, Patel A, Gerber SI, Kim L, Tong S, Lu X, Lindstrom S, Pallansch MA, Weldon WC, Biggs HM, Uyeki TM, Pillai SK (2020) First case of 2019 novel coronavirus in the United States. N Engl J Med. https://doi.org/10.1056/NEJMoa2001191
Zhou Y, Hou Y, Shen J, Huang Y, Martin W, Cheng F (2020) Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discov 6:14–18
Article
CAS
PubMed
PubMed Central
Google Scholar
Gu J, Han B, Wang J (2020) COVID-19: gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology. https://doi.org/10.1053/j.gastro.2020.02.054
Calisher C, Carroll D, Colwell R, Corley RB, Daszak P, Drosten C, Enjuanes L, Farrar J, Field H, Golding J (2020) Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19. Lancet. 395(10226):e42–e43
Article
CAS
PubMed
PubMed Central
Google Scholar
To KK-W, Tsang OT-Y, Yip CC-Y, Chan K-H, Wu T-C, Chan JM-C, Leung W-S, Chik TS-H, Choi CY-C, Kandamby DH (2020) Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis 71(15):841–843. https://doi.org/10.1093/cid/ciaa149
Article
CAS
PubMed
Google Scholar
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, Bi Y, Ma X, Zhan F, Liang W, Hu T, Zhou H, Hu Z, Zhou W, Zhao L, Chen J, Meng Y, Wang J, Yang L, Yuan J, Xie Z, Ma J, Liu WJ, Wang D, Xu W, Holmes EC, Gao GF, Wu G, Chen W, Shi W, Tan W (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. https://doi.org/10.1016/S0140-6736(20)30251-8
Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, Si H-R, Zhu Y, Li B, Huang C-L, Chen H-D, Chen J, Luo Y, Guo H, Jiang R-D, Liu M-Q, Chen Y, Shen X-R, Wang X, Zheng X-S, Zhao K, Chen Q-J, Deng F, Liu L-L, Yan B, Zhan F-X, Wang Y-Y, Xiao G-F, Shi Z-L (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 579:270–273. https://doi.org/10.1038/s41586-020-2012-7
Article
CAS
PubMed
PubMed Central
Google Scholar
Huang Q, Herrmann A (2020) Fast assessment of human receptor-binding capability of 2019 novel coronavirus (2019-nCoV). Bio Rxiv. https://doi.org/10.1101/2020.02.01.930537
Zhang H, Kang Z, Gong H, Xu D, Wang J, Li Z, Cui X, Xiao J, Meng T, Wang Z, Liu J, Xu H (2020) The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes. bioRxiv:927806. https://doi.org/10.1101/2020.01.30.927806
Chang, L., Yan,Y., Wang, L. (2020) Coronavirus disease 2019: coronaviruses and blood safety. Transfus Med Rev. https://doi.org/10.1016/j.tmrv.2020.02.003.
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y. (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China. Lancet. https://doi.org/10.1016/s0140-6736(20)30183-5.
Prakash P, Misra A, Surin WR, Jain M, Bhatta RS, Pal R (2011) Anti-platelet effects of Curcuma oil in experimental models of myocardial ischemia-reperfusion and thrombosis. Thromb Res 127:111–118. https://doi.org/10.1016/j.thromres.2010.11.007
Article
CAS
PubMed
Google Scholar
Kuroda M, Mimaki Y, Nishiyama T, Mae T, Kishida H, Tsukagawa K (2005) Hypoglycemic effects of turmeric (Curcuma longa L. Rhizomes) on genetically diabetic KK-Ay mice. Biol Pharm Bull 5:937–939
Article
Google Scholar
Aggarwal BB, Kumar A, Bharti AC (2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23(1A):363–398
CAS
PubMed
Google Scholar
Parthasarathy VA, Chempakam B, Zachariah TJ (2008) Chemistry of spices. United Kingdom. CABI:445–447
Haddad M, Sauvain M, Deharo E (2010) Curcuma as a parasiticidal agent: a review. Planta Med 77:672–678. https://doi.org/10.1055/s-0030-1250549
Article
CAS
PubMed
Google Scholar
Abe Y, Hashimoto S, Horie T (1999) Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol Res 39(1):41–47
Article
CAS
PubMed
Google Scholar
Gupta B, Ghosh B (1999) Curcuma longa inhibits TNF-alpha induced expression of adhesion molecules on human umbilical vein endothelial cells. Int J Immunopharmacol 21(11):745–757
Article
CAS
PubMed
Google Scholar
Srivastava R, Dikshit M, Srimal RC, Dhawan BN (1985) Anti-thrombotic effect of curcumin. Thromb Res 40(3):413–417
Article
CAS
PubMed
Google Scholar
Bhatia A, Singh GB, Khanna NM (1964) Effect of curcumin, its alkali salts and Curcuma longa oil in histamine-induced gastric ulceration. Indian J Exp Biol 2:158–160
Google Scholar
Ramirez-Tortosa MC, Mesa MD, Aguilera MC, Quiles JL, Baro L, Ramirez-Tortosa CL, Martinez-Victoria E, Gil A (1999) Oral administration of a turmeric extract inhibits LDL oxidation and has hypocholesterolemic effects in rabbits with experimental atherosclerosis. Atherosclerosis 147(2):371–378
Article
CAS
PubMed
Google Scholar
Kim DS, Park SY, Kim JK (2001) Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from betaA(1-42) insult. Neurosci Lett 303(1):57–61
Article
CAS
PubMed
Google Scholar
Boopathi C (2000) Andrographis spp.: a source of bitter compounds for medicinal use. Anc Sci Life 19(3-4):164–168
CAS
PubMed
PubMed Central
Google Scholar
Jarukamjorn K, Nemoto N (2008) Pharmacological aspects of Andrographis paniculata on health and its major diterpenoid constituent andrographolide. J Health Sci 54(4):370–381
Article
CAS
Google Scholar
Kabir MH, Hasan N, Rahman MM, Khan JA, Hoque NT, Quddus Bhuiyan MR, Mou SM, Jahan R, Rahmatullah M (2014) A survey of medicinal plants used by the Deb barma clan of the Tripura tribe of Moulvibazar district, Bangladesh. J Ethnobiol Ethnomed 10(1):19
Article
PubMed
PubMed Central
Google Scholar
Borhanuddin M, Shamsuzzoha M, Hussain AH (1994) Hypoglycaemic effects of Andrographis paniculata Nees on nondiabetic rabbits. Bangladesh Med Res Counc Bull 20(1):24–26
CAS
PubMed
Google Scholar
Akbar S (2011) Andrographis paniculata: a review of pharmacological activities and clinical effects. Altern Med Rev 16(1):66–77
PubMed
Google Scholar
Chaturvedi GN, Tomar GS, Tiwari SK, Singh KP (1983) Clinical studies on Kalmegh (Andrographis paniculata Nees) in infective hepatitis. J Int Inst Ayurveda 2:208–211
Google Scholar
Dua VK, Ojha VP, Roy R, Joshi BC, Valecha N, Devi CU et al (2004) Anti-malarial activity of some xanthones isolated from the roots of Andrographis paniculata. J Ethnopharmacol 95:247–251
Article
CAS
PubMed
Google Scholar
Parichatikanond W, Suthisisang C, Dhepakson P, Herunsalee A (2010) Study of anti-inflammatory activities of the pure compounds from Andrographis paniculata (Burm.f.) Nees and their effects on gene expression. Int Immunopharmacol 10:1361–1373
Article
CAS
PubMed
Google Scholar
Jade SR, Suburb GS, Matthews C, Hamzah AS, Lapis NH, Saad MS (2007) Semisynthesis and in vitro anticancer activities of andrographolide analogues. Phytochem 68:904–912
Article
Google Scholar
Husen R, Pihie AH, Nallappan M (2004) Screening for antihyperglycaemic activity in several local herbs of Malaysia. J Ethnopharmacol 95:205–208
Article
PubMed
Google Scholar
Kalirajan R, Mohammed rafick MH, Sankar S, Gowramma B (2018) Green synthesis of some novel chalcone and isoxazole substituted 9-anilinoacridine derivatives and evaluation of their antimicrobial and larvicidal activities. Indian J Chem 57B:583–590
CAS
Google Scholar
Kalirajan R, Muralidharan V, Jubie S, Sankar S (2013) Microwave assisted synthesis, characterization and evaluation for their antimicrobial activities of some novel pyrazole substituted 9-anilino acridine derivatives. Int J Health Allied Sci 2(2):81–87
Article
Google Scholar
Kalirajan R, Muralidharan V, Jubie S, Gowramma B, Gomathy S, Sankar S, Elango K (2012) Synthesis of some novel pyrazole substituted 9-anilinoacridine derivatives and evaluation for their antioxidant and cytotoxic activities. J Heterocyclic Chem 49:748–754
Article
CAS
Google Scholar
Kalirajan R, Mohammed rafick MH, Jubie S, Sankar S (2012) Docking studies, synthesis, characterization and evaluation of their antioxidant and cytotoxic activities of some novel isoxazole substituted 9-anilinoacridine derivatives. Sci World J:165258. https://doi.org/10.1100/2012/165258
Kalirajan R, kulshrestha V, Sankar S, Jubie S (2012) Docking studies, synthesis, characterization of some novel oxazine substituted 9-anilinoacridine derivatives and evaluation for their anti-oxidant and anticancer activities as topo isomerase II inhibitors. Eur J Med Chem 56:217–224
Article
CAS
PubMed
Google Scholar
Kalirajan R, Rathore L, Jubie S, Gowramma B, Gomathy S, Sankar S (2011) Microwave assisted synthesis of some novel pyrazole substituted benzimidazoles and evaluation of their biological activities. Indian J Chem 50B:1794–1801
CAS
Google Scholar
Kalirajan R, Sankar S, Jubie S, Gowramma B (2017) Molecular docking studies and in-silico ADMET screening of some novel oxazine substituted 9-anilinoacridines as topoisomerase II inhibitors. Indian J Pharm Educ Res 51(1):110–115
Article
CAS
Google Scholar
Kalirajan R, Gowramma B, Jubie S, Sankar S (2017) Molecular docking studies and in silico ADMET screening of some novel heterocyclic substituted 9-anilinoacridines as topoisomerase II inhibitors. JSM Chem 5(1):1039–1044
Google Scholar
Kalirajan R, Gaurav K, Pandiselvi A, Gowramma B, Sankar S (2019) Novel thiazine substituted 9-anilinoacridines: synthesis, antitumour activity and structure-activity relationships. Anti-Cancer Agents Med Chem 11:1350–1358. https://doi.org/10.2174/1871520619666190408134224
Article
CAS
Google Scholar
Kalirajan R, Vivek kulshrestha, Sankar, S. (2018) Synthesis, characterization and evaluation for antitumour activity of some novel oxazine substituted 9-anilinoacridines and their 3D-QSAR studies. Indian J Pharm Sci 80(5):921–929
Article
CAS
Google Scholar
Kalirajan R, Pandiselvi A, Gowramma B, Balachandran P (2019) In-silico design, ADMET screening, MM-GBSA binding free energy of some novel isoxazole substituted9-anilinoacridines as HER2 inhibitors targeting breast cancer. Curr Drug Res Rev 11(2):118–128
Article
CAS
PubMed
Google Scholar
Sastry GM, Adzhigirey M, Day T, Annabhimoju R, Sherman W (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comp Aided Mol Design 27:221–234
Article
Google Scholar
Jacobson MP, Pincus DL, Rapp CS, Day TJF, Honig B, Shaw DE, Friesner RA (2004) A hierarchical approach to all-atom protein loop prediction. Proteins 55:351–367
Article
CAS
PubMed
Google Scholar
Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, Mainz DT (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein–ligand complexes. J Med Chem 49:6177–6196
Article
CAS
PubMed
Google Scholar
Li J, Abel R, Zhu K, Cao Y, Zhao S, Friesner RA (2011) The VSGB 2.0 model: a next generation energy model for high resolution protein structure modelling. Proteins 79:2794–2812
Article
CAS
PubMed
PubMed Central
Google Scholar
Cross R (2020) Chloroquine’s use to treat COVID-19 is backed by US government, but many questions remain. Drug Dev 98(12)